Patents by Inventor Sven G. ENTERLEIN

Sven G. ENTERLEIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteins
    Patent number: 10611827
    Abstract: The disclosure provides non-human primate-derived binding molecules, e.g., antibodies or antigen-binding fragments thereof, that can bind to orthologous epitopes found on two or more filovirus species or strains.
    Type: Grant
    Filed: October 27, 2015
    Date of Patent: April 7, 2020
    Assignees: INTEGRATED BIOTHERAPEUTICS, INC., THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: Mohammad Javad Aman, Frederick Wayne Holtsberg, Sven G. Enterlein, Katie A. Howell, Zhen-Yong Keck, Steven K. H. Foung
  • PAN-EBOLA AND PAN-FILOVIRUS PROTECTIVE EPITOPES, ANTIBODIES, AND ANTIBODY COCKTAILS
    Publication number: 20180237502
    Abstract: This disclosure provides a method for preventing, treating, or managing a filovirus infection in a subject, where the method includes administering to a subject in need thereof an effective amount of at least one binding molecule that includes a binding domain that specifically binds to an orthologous filovirus glycoprotein epitope, wherein the binding domain specifically binds to the epitope on two or more filovirus species or strains.
    Type: Application
    Filed: March 11, 2016
    Publication date: August 23, 2018
    Applicants: Integrated BioTherapeutics, Inc., Integrated BioTherapeutics, Inc.
    Inventors: Mohammad Javad Aman, Frederick Wayne Holtsberg, Sven G. Enterlein, Katie A. Howell
  • NON-HUMAN PRIMATE-DERIVED PAN-EBOLA AND PAN-FILOVIRUS MONOCLONAL ANTIBODIES DIRECTED AGAINST ENVELOPE GLYCOPROTEINS
    Publication number: 20170334973
    Abstract: The disclosure provides non-human primate-derived binding molecules, e.g., antibodies or antigen-binding fragments thereof, that can bind to orthologous epitopes found on two or more filovirus species or strains.
    Type: Application
    Filed: October 27, 2015
    Publication date: November 23, 2017
    Inventors: Mohammad Javad AMAN, Frederick Wayne HOLTSBERG, Sven G. ENTERLEIN, Katie A. HOWELL, Zhen-Yong KECK, Steven K. H. FOUNG